# Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

> **NCT06122961** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 18198 (actual)

## Conditions studied

- Cardiovascular Risk
- Heart Failure
- Chronic Kidney Disease

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT06122961
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-23
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 18198 (ACTUAL)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06122961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06122961, "Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06122961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*